GalcanezumAb for prevention of high frequency episodic and chronic migraine in the Real Life in ITaly: a multicenter prospective cohort study (the GARLIT study)

被引：0
|
作者：
Vernieri, F. [1 ]
Altamura, C. [1 ]
Brunelli, N. [1 ]
Costa, C. M. [1 ]
Aurilia, C. [2 ]
Egeo, G. [2 ]
Fofi, L. [2 ]
Favoni, V. [3 ]
Pierangeli, G. [3 ]
Lovati, C. [4 ]
Aguggia, M. [5 ]
Bertuzzo, D. [5 ]
D'Onofrio, F. [6 ]
Doretti, A. [7 ,8 ]
Di Fiore, P. [9 ]
Frediani, F. [9 ]
Finocchi, C. [10 ]
Rao, R. [11 ]
Di Cola, F. Schiano [11 ]
Bono, F. [12 ]
Ranieri, A. [13 ]
Albanese, M. [14 ]
Cevoli, S. [3 ]
Barbanti, P. [2 ]
机构：
[1] Campus Biomed Univ Rome, Neurol, Rome, Italy
[2] IRCCS San Raffaele Pisana, Headache & Pain Unit, Rome, Italy
[3] IRCCS Ist Sci Neurol Bologna, Bologna, Italy
[4] Univ Hosp L Sacco, Neurol Unit, Milan, Italy
[5] Asti Hosp, Neurol & Stroke Unit, Asti, Italy
[6] Giuseppe Moscati Hosp, Neurol Unit, Avellino, Italy
[7] Ist Auxol Italiano, IRCCS, Stroke Unit, Neurol, Milan, Italy
[8] Lab Neurosci, Milan, Italy
[9] San Carlo Borromeo Hosp, ASST Santi Paolo & Carlo Milan, Headache Ctr, Neurol & Stroke Unit, Milan, Italy
[10] IRCCS Osped Policlin San Martino, Genoa, Italy
[11] Univ Brescia, Dept Clin & Expt Sci, Neurol Unit, Brescia, Italy
[12] AOU Mater Domini, Neurol Unit, Catanzaro, Italy
[13] A Cardarelli Hosp, Headache Ctr, Neurol & Stroke Unit, Naples, Italy
[14] Univ Hosp Rome Tor Vergata, Dept Syst Med, Rome, Italy
来源：
CEPHALALGIA | 2021年 / 41卷 / 1_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
AL057
引用
收藏
页码：29 / 30
页数：2
相关论文
共 50 条
  • [1] Galcanezumab for the prevention of high frequency episodic and chronic migraine in real life in Italy: a multicenter prospective cohort study (the GARLIT study)
    Vernieri, Fabrizio
    Altamura, Claudia
    Brunelli, Nicoletta
    Costa, Carmelina Maria
    Aurilia, Cinzia
    Egeo, Gabriella
    Fofi, Luisa
    Favoni, Valentina
    Pierangeli, Giulia
    Lovati, Carlo
    Aguggia, Marco
    d'Onofrio, Florindo
    Doretti, Alberto
    Di Fiore, Paola
    Finocchi, Cinzia
    Rao, Renata
    Bono, Francesco
    Ranieri, Angelo
    Albanese, Maria
    Cevoli, Sabina
    Barbanti, Piero
    JOURNAL OF HEADACHE AND PAIN, 2021, 22 (01):
  • [2] Galcanezumab for the prevention of high frequency episodic and chronic migraine in real life in Italy: a multicenter prospective cohort study (the GARLIT study)
    Fabrizio Vernieri
    Claudia Altamura
    Nicoletta Brunelli
    Carmelina Maria Costa
    Cinzia Aurilia
    Gabriella Egeo
    Luisa Fofi
    Valentina Favoni
    Giulia Pierangeli
    Carlo Lovati
    Marco Aguggia
    Florindo d’Onofrio
    Alberto Doretti
    Paola Di Fiore
    Cinzia Finocchi
    Renata Rao
    Francesco Bono
    Angelo Ranieri
    Maria Albanese
    Sabina Cevoli
    Piero Barbanti
    The Journal of Headache and Pain, 2021, 22
  • [3] Galcanezumab for prevention of episodic and chronic migraine in real life in Colombia and Mexico: a multicenter prospective cohort study
    Munoz-Ceron, J.
    Velez, K.
    Rodriguez, I.
    Hernandez, N.
    Guerra, C.
    Bohorquez, S.
    Jimenez, J. D.
    Moreno, C.
    Ramos, M.
    Cavanzo, P.
    Rojas, Y.
    Bernal, R.
    Lopez, R.
    Gallo, L.
    JOURNAL OF HEADACHE AND PAIN, 2024, 25
  • [4] The real-life early and continuative response to Galcanezumab in chronic migraine: 3-month analysis of the multicenter prospective cohort GARLIT study
    Altamura, C.
    Brunelli, N.
    Costa, C. M.
    Aurilia, C.
    Egeo, G.
    Fofi, L.
    Favoni, V.
    Pierangeli, G.
    Messina, R.
    Filippi, M.
    Colombo, B.
    Lovati, C.
    Aguggia, M.
    Bertuzzo, D.
    D'Onofrio, F.
    Doretti, A.
    Di Fiore, P.
    Frediani, F.
    Finocchi, C.
    Rao, R.
    Di Cola, F. Schiano
    Bono, F.
    Ranieri, A.
    Albanese, M.
    Cevoli, S.
    Barbanti, P.
    Vernieri, F.
    JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 123 - 123
  • [5] The real-life early and continuative response to Galcanezumab in chronic migraine: 3-month analysis of the multicenter prospective cohort GARLIT study
    Altamura, C.
    Brunelli, N.
    Costa, C. M.
    Aurilia, C.
    Egeo, G.
    Fofi, L.
    Favoni, V.
    Pierangeli, G.
    Messina, R.
    Filippi, M.
    Colombo, B.
    Lovati, C.
    Aguggia, M.
    Bertuzzo, D.
    D'Onofrio, F.
    Doretti, A.
    Di Fiore, P.
    Frediani, F.
    Finocchi, C.
    Rao, R.
    Di Cola, F. Schiano
    Bono, F.
    Ranieri, A.
    Albanese, M.
    Cevoli, S.
    Barbanti, P.
    Vernieri, F.
    CEPHALALGIA, 2021, 41 (1_SUPPL) : 183 - 184
  • [6] Conversion from chronic to episodic migraine in patients treated with galcanezumab in real life in Italy: the 12-month observational, longitudinal, cohort multicenter GARLIT experience
    Altamura, Claudia
    Brunelli, Nicoletta
    Marcosano, Marilena
    Aurilia, Cinzia
    Egeo, Gabriella
    Lovati, Carlo
    Favoni, Valentina
    Perrotta, Armando
    Maestrini, Ilaria
    Di Cola, Francesca Schiano
    d'Onofrio, Florindo
    Finocchi, Cinzia
    Bertuzzo, Davide
    Bono, Francesco
    Ranieri, Angelo
    Albanese, Maria
    Messina, Roberta
    Doretti, Alberto
    Di Piero, Vittorio
    Cevoli, Sabina
    Barbanti, Piero
    Vernieri, Fabrizio
    JOURNAL OF NEUROLOGY, 2022, 269 (11) : 5848 - 5857
  • [7] Conversion from chronic to episodic migraine in patients treated with galcanezumab in real life in Italy: the 12-month observational, longitudinal, cohort multicenter GARLIT experience
    Claudia Altamura
    Nicoletta Brunelli
    Marilena Marcosano
    Cinzia Aurilia
    Gabriella Egeo
    Carlo Lovati
    Valentina Favoni
    Armando Perrotta
    Ilaria Maestrini
    Francesca Schiano Di Cola
    Florindo d’Onofrio
    Cinzia Finocchi
    Davide Bertuzzo
    Francesco Bono
    Angelo Ranieri
    Maria Albanese
    Roberta Messina
    Alberto Doretti
    Vittorio Di Piero
    Sabina Cevoli
    Piero Barbanti
    Fabrizio Vernieri
    Journal of Neurology, 2022, 269 : 5848 - 5857
  • [8] Erenumab in the prevention of high-frequency episodic and chronic migraine: Erenumab in Real Life in Italy (EARLY), the first Italian multicenter, prospective real-life study
    Barbanti, Piero
    Aurilia, Cinzia
    Egeo, Gabriella
    Fofi, Luisa
    Cevoli, Sabina
    Colombo, Bruno
    Filippi, Massimo
    Frediani, Fabio
    Bono, Francesco
    Grazzi, Licia
    Salerno, Antonio
    Mercuri, Bruno
    Carnevale, Antonio
    Altamura, Claudia
    Vernieri, Fabrizio
    HEADACHE, 2021, 61 (02): : 363 - 372
  • [9] Maintenance of response and predictive factors of 1-year GalcanezumAb treatment in real-life migraine patients in Italy: The multicenter prospective cohort GARLIT study
    Vernieri, Fabrizio
    Brunelli, Nicoletta
    Marcosano, Marilena
    Aurilia, Cinzia
    Egeo, Gabriella
    Lovati, Carlo
    Favoni, Valentina
    Perrotta, Armando
    Maestrini, Ilaria
    Rao, Renata
    d'Onofrio, Luigi
    Finocchi, Cinzia
    Aguggia, Marco
    Bono, Francesco
    Ranieri, Angelo
    Albanese, Maria
    Di Piero, Vittorio
    Cevoli, Sabina
    Altamura, Claudia
    Barbanti, Piero
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 (01) : 224 - 234
  • [10] The First, Italian, Multicenter, Real-life Study with Erenumab in the Prevention of High Frequency Episodic and Chronic Migraine
    Barbanti, Piero
    Aurilia, Cinzia
    Cevoli, Sabina
    Colombo, Bruno
    Frediani, Fabio
    Bono, Francesco
    Grazzi, Licia
    D'Amico, Domenico
    Salerno, Antonio
    Mercuri, Bruno
    Carnevale, Antonio
    Vollono, Catello
    Egeo, Gabriella
    Fofi, Luisa
    Altamura, Claudia
    Costa, Carmen
    Brunelli, Nicoletta
    Fallacara, Adriana
    Pierangeli, Giulia
    Favoni, Valentina
    Messina, Roberta
    Filippi, Massimo
    Di Fiore, Paola
    Santangelo, Domenico
    Vernieri, Fabrizio
    NEUROLOGY, 2020, 94 (15)
12345